A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
Condition: Schizophrenia Interventions: Drug: SEP-363856; Drug: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole) Sponsor: Sunovion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2022 Category: Research Source Type: clinical trials